DOI : 10.1055/s-00000085

The Thoracic and Cardiovascular Surgeon

Issue S 01 · Volume 69 · January 2021 DOI: 10.1055/s-011-50390


50th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG)
Online, 26.–28.02.2021

Abstracts (HTML) List of Authors
DGTHG-V35
Zayat, R.; Allham, O.; Rotaru, A.; Diab, A. H.; Huenges, K.; Panholzer, B.; Schnoering, H.; Matschke, K.; Cremer, J.; Autschbach, R.; Haneya, A.: Hemocompatibility-Related Adverse Events in a Real-World Cohort Comparing Three Different LVADs, the HeartWare, HeartMate II, and HeartMate 3: A Multicenter Observational Study
DGTHG-V36
Mulzer, J.: Diagnosis and Treatment Strategies of Outflow Graft Obstruction of the Fully Magnetically Levitated Continuous Flow Centrifugal Left Ventricular Assist Device
DGTHG-V37
Tie, H.; Welp, H.; Martens, S.; Seiler, M.; Albers, P.; Müller, K. M.; Li, Z.; Martens, S.: Impact of Cardiac Fibrosis and Collagens on Right Ventricular Failure and Acute Kidney Injury in Patients after Continuous-Flow Left Ventricular Assist Devices
DGTHG-V38
Zipfel, S.; Biancari, F.; Mariscalco, G.; Dalén, M.; Settembre, N.; Welp, H.; Perrotti, A.; Wiebe, K.; Leo, E.; Loforte, A.; Chocron, S.; Pacini, D.; Juvonen, T.; Broman, L. M.; Di Perna, D.; Yusuff, H.; Harvey, C.; Mongardon, N.; Maureira, J. P.; Levy, B.; Falk, L.; Ruggieri, V. G.; Kluge, S.; Reichenspurner, H.; Folliguet, T.; Fiore, A.: Extracorporeal Membrane Oxygenation for Patients with Severe COVID-19-Related ARDS: A European Multicenter Analysis
DGTHG-V39
Exarchos, V.; Meyborg, H.; Krüger, K.; Giampietro, C.; Moimas, S.; Chala, N.; Cesarovic, N.; Emmert, M. Y.; Falk, V.; Ferrari, A.; Shafti, M. T.Z. Nazari: The Rejuvenative Impact of Anisotropic Topographies on Senescent Endothelial Cells
DGTHG-V40
Pausch, J.; Bhadra, O. D.; Barten, M.; Reichenspurner, H.; Bernhardt, A.: Extracorporeal Cytokine Hemoadsorption during High-Risk LVAD Implantation: Is It Really Worth?
DGTHG-V41
Tie, H.; Welp, H.; Martens, S.; Sindermann, J.; Martens, S.: Calcium-Channel Blockers (Amlodipine) Therapy Is Associated with Improved Survival in Patients after Continuous-Flow Left Ventricular Assist Devices